(Q40604725)

22 September 2017

title

Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells (English)

1 reference

22 September 2017

1 reference

1

1 reference

22 September 2017

8

1 reference

22 September 2017

Randi Utne Holt

2

1 reference

22 September 2017

Anne-Tove Brenne

3

1 reference

22 September 2017

Henrik Hjorth-Hansen

4

1 reference

22 September 2017

Anders Waage

5

1 reference

22 September 2017

Oyvind Hjertner

6

1 reference

22 September 2017

Anders Sundan

7

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

22 September 2017

1 reference

22 September 2017

volume

23

1 reference

22 September 2017

issue

17

1 reference

22 September 2017

page(s)

3024-3032

1 reference

Bone morphogenetic protein-5 (BMP-5) promotes dendritic growth in cultured sympathetic neurons

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207386

Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207386

Activin A induces apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207386

The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207386

Heparan sulfate proteoglycans retain Noggin at the cell surface: a potential mechanism for shaping bone morphogenetic protein gradients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207386

Molecular cloning of a novel type I receptor serine/threonine kinase for the TGF beta superfamily from rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207386

Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207386

Interleukin-21 is a growth and survival factor for human myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207386

7 January 2021

Intravenous administration of bone morphogenetic protein-7 after ischemia improves motor function in stroke rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207386

7 January 2021

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207386

7 January 2021

TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207386

7 January 2021

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207386

7 January 2021

Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207386

7 January 2021

Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207386

7 January 2021

Characterization of type I receptors for transforming growth factor-beta and activin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207386

7 January 2021

Bone: formation by autoinduction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207386

7 January 2021

Overexpression of bone morphogenetic protein-6 (BMP-6) in murine epidermis suppresses skin tumor formation by induction of apoptosis and downregulation of fos/jun family members

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207386

7 January 2021

Smad5, a tumor suppressor candidate at 5q31.1, is hemizygously lost and not mutated in the retained allele in human leukemia cell line HL60.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207386

7 January 2021

The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207386

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207386

1 reference

Dimensions Publication ID

22 September 2017

1036758056

0 references

1 reference